nodes	percent_of_prediction	percent_of_DWPC	metapath
Docetaxel—NR1I2—Ethinyl Estradiol—osteoporosis	0.13	0.21	CbGbCtD
Docetaxel—NR1I2—Estradiol—osteoporosis	0.0835	0.135	CbGbCtD
Docetaxel—ABCC10—Estradiol—osteoporosis	0.0587	0.0949	CbGbCtD
Docetaxel—ABCC1—Zoledronate—osteoporosis	0.0464	0.0751	CbGbCtD
Docetaxel—SLCO1B3—Conjugated Estrogens—osteoporosis	0.0373	0.0604	CbGbCtD
Docetaxel—SLCO1B3—Estradiol—osteoporosis	0.0328	0.053	CbGbCtD
Docetaxel—CYP1B1—Estradiol—osteoporosis	0.0319	0.0516	CbGbCtD
Docetaxel—ABCC2—Ethinyl Estradiol—osteoporosis	0.026	0.0421	CbGbCtD
Docetaxel—ABCC1—Conjugated Estrogens—osteoporosis	0.0258	0.0418	CbGbCtD
Docetaxel—ABCC2—Conjugated Estrogens—osteoporosis	0.0191	0.0309	CbGbCtD
Docetaxel—ABCG2—Conjugated Estrogens—osteoporosis	0.0173	0.0279	CbGbCtD
Docetaxel—ABCG2—Estradiol—osteoporosis	0.0152	0.0245	CbGbCtD
Docetaxel—CYP3A7—Estradiol—osteoporosis	0.0112	0.0181	CbGbCtD
Docetaxel—CYP3A7-CYP3A51P—Estradiol—osteoporosis	0.0112	0.0181	CbGbCtD
Docetaxel—ABCB1—Ethinyl Estradiol—osteoporosis	0.00848	0.0137	CbGbCtD
Docetaxel—CYP3A5—Estradiol—osteoporosis	0.0084	0.0136	CbGbCtD
Docetaxel—CYP3A4—Estropipate—osteoporosis	0.00789	0.0128	CbGbCtD
Docetaxel—CYP3A4—Calcitriol—osteoporosis	0.00789	0.0128	CbGbCtD
Docetaxel—CYP3A4—Ergocalciferol—osteoporosis	0.0063	0.0102	CbGbCtD
Docetaxel—ABCB1—Conjugated Estrogens—osteoporosis	0.00622	0.0101	CbGbCtD
Docetaxel—ABCB1—Estradiol—osteoporosis	0.00546	0.00885	CbGbCtD
Docetaxel—CYP3A4—Raloxifene—osteoporosis	0.00526	0.00852	CbGbCtD
Docetaxel—CYP3A4—Ethinyl Estradiol—osteoporosis	0.00508	0.00822	CbGbCtD
Docetaxel—CYP3A4—Cholecalciferol—osteoporosis	0.00406	0.00658	CbGbCtD
Docetaxel—CYP3A4—Conjugated Estrogens—osteoporosis	0.00373	0.00604	CbGbCtD
Docetaxel—CYP3A4—Estradiol—osteoporosis	0.00327	0.0053	CbGbCtD
Docetaxel—Paclitaxel—CYP19A1—osteoporosis	0.00146	1	CrCbGaD
Docetaxel—KIF11—Fulvestrant—Estradiol—osteoporosis	0.00145	0.463	CbGdCrCtD
Docetaxel—BCL2—Fulvestrant—Estradiol—osteoporosis	0.00105	0.335	CbGdCrCtD
Docetaxel—TUBB6—Fulvestrant—Estradiol—osteoporosis	0.000381	0.121	CbGdCrCtD
Docetaxel—TUBB6—Levorphanol—Estradiol—osteoporosis	0.000252	0.0802	CbGdCrCtD
Docetaxel—KIF11—bone marrow—osteoporosis	0.000247	0.14	CbGeAlD
Docetaxel—MAP4—uterus—osteoporosis	0.000134	0.0759	CbGeAlD
Docetaxel—BCL2—uterus—osteoporosis	0.000122	0.069	CbGeAlD
Docetaxel—EGFR—uterus—osteoporosis	0.00012	0.0682	CbGeAlD
Docetaxel—TUBB1—bone marrow—osteoporosis	0.000111	0.063	CbGeAlD
Docetaxel—BCL2—bone marrow—osteoporosis	0.000103	0.0586	CbGeAlD
Docetaxel—Visual impairment—Estradiol—osteoporosis	0.000102	0.000484	CcSEcCtD
Docetaxel—Anorexia—Pamidronate—osteoporosis	0.000102	0.000483	CcSEcCtD
Docetaxel—Chest pain—Zoledronate—osteoporosis	0.000102	0.000483	CcSEcCtD
Docetaxel—Arthralgia—Zoledronate—osteoporosis	0.000102	0.000483	CcSEcCtD
Docetaxel—Myalgia—Zoledronate—osteoporosis	0.000102	0.000483	CcSEcCtD
Docetaxel—Palpitations—Conjugated Estrogens—osteoporosis	0.000102	0.000483	CcSEcCtD
Docetaxel—Insomnia—Risedronate—osteoporosis	0.000102	0.000482	CcSEcCtD
Docetaxel—Loss of consciousness—Conjugated Estrogens—osteoporosis	0.000101	0.00048	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—osteoporosis	0.000101	0.00048	CcSEcCtD
Docetaxel—Paraesthesia—Risedronate—osteoporosis	0.000101	0.000479	CcSEcCtD
Docetaxel—Pruritus—Estropipate—osteoporosis	0.000101	0.000478	CcSEcCtD
Docetaxel—Asthenia—Alendronate—osteoporosis	0.000101	0.000477	CcSEcCtD
Docetaxel—Hypersensitivity—Ibandronate—osteoporosis	0.000101	0.000477	CcSEcCtD
Docetaxel—Cough—Conjugated Estrogens—osteoporosis	0.000101	0.000477	CcSEcCtD
Docetaxel—Dyspnoea—Risedronate—osteoporosis	0.0001	0.000476	CcSEcCtD
Docetaxel—Erythema multiforme—Estradiol—osteoporosis	0.0001	0.000475	CcSEcCtD
Docetaxel—Hypotension—Pamidronate—osteoporosis	0.0001	0.000474	CcSEcCtD
Docetaxel—Convulsion—Conjugated Estrogens—osteoporosis	9.99e-05	0.000473	CcSEcCtD
Docetaxel—Dry mouth—Zoledronate—osteoporosis	9.97e-05	0.000473	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Ethinyl Estradiol—osteoporosis	9.97e-05	0.000472	CcSEcCtD
Docetaxel—Fatigue—Ethinyl Estradiol—osteoporosis	9.96e-05	0.000472	CcSEcCtD
Docetaxel—Pruritus—Alendronate—osteoporosis	9.93e-05	0.00047	CcSEcCtD
Docetaxel—Dyspepsia—Risedronate—osteoporosis	9.91e-05	0.00047	CcSEcCtD
Docetaxel—Eye disorder—Estradiol—osteoporosis	9.91e-05	0.00047	CcSEcCtD
Docetaxel—Constipation—Ethinyl Estradiol—osteoporosis	9.88e-05	0.000468	CcSEcCtD
Docetaxel—Confusional state—Zoledronate—osteoporosis	9.86e-05	0.000467	CcSEcCtD
Docetaxel—Hypersensitivity—Calcitriol—osteoporosis	9.85e-05	0.000467	CcSEcCtD
Docetaxel—Cardiac disorder—Estradiol—osteoporosis	9.84e-05	0.000466	CcSEcCtD
Docetaxel—Flushing—Estradiol—osteoporosis	9.84e-05	0.000466	CcSEcCtD
Docetaxel—Chest pain—Conjugated Estrogens—osteoporosis	9.82e-05	0.000465	CcSEcCtD
Docetaxel—Arthralgia—Conjugated Estrogens—osteoporosis	9.82e-05	0.000465	CcSEcCtD
Docetaxel—Myalgia—Conjugated Estrogens—osteoporosis	9.82e-05	0.000465	CcSEcCtD
Docetaxel—Asthenia—Ibandronate—osteoporosis	9.8e-05	0.000464	CcSEcCtD
Docetaxel—Nausea—Etidronic acid—osteoporosis	9.78e-05	0.000463	CcSEcCtD
Docetaxel—Anaphylactic shock—Zoledronate—osteoporosis	9.78e-05	0.000463	CcSEcCtD
Docetaxel—Oedema—Zoledronate—osteoporosis	9.78e-05	0.000463	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Conjugated Estrogens—osteoporosis	9.75e-05	0.000462	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Pamidronate—osteoporosis	9.75e-05	0.000462	CcSEcCtD
Docetaxel—Diarrhoea—Estropipate—osteoporosis	9.75e-05	0.000462	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Risedronate—osteoporosis	9.72e-05	0.000461	CcSEcCtD
Docetaxel—Infection—Zoledronate—osteoporosis	9.71e-05	0.00046	CcSEcCtD
Docetaxel—Fatigue—Risedronate—osteoporosis	9.71e-05	0.00046	CcSEcCtD
Docetaxel—Insomnia—Pamidronate—osteoporosis	9.68e-05	0.000459	CcSEcCtD
Docetaxel—Pruritus—Ibandronate—osteoporosis	9.67e-05	0.000458	CcSEcCtD
Docetaxel—Pain—Risedronate—osteoporosis	9.63e-05	0.000456	CcSEcCtD
Docetaxel—Constipation—Risedronate—osteoporosis	9.63e-05	0.000456	CcSEcCtD
Docetaxel—Angiopathy—Estradiol—osteoporosis	9.62e-05	0.000456	CcSEcCtD
Docetaxel—Shock—Zoledronate—osteoporosis	9.62e-05	0.000456	CcSEcCtD
Docetaxel—Paraesthesia—Pamidronate—osteoporosis	9.61e-05	0.000455	CcSEcCtD
Docetaxel—Diarrhoea—Alendronate—osteoporosis	9.6e-05	0.000455	CcSEcCtD
Docetaxel—Asthenia—Calcitriol—osteoporosis	9.6e-05	0.000455	CcSEcCtD
Docetaxel—Nervous system disorder—Zoledronate—osteoporosis	9.59e-05	0.000454	CcSEcCtD
Docetaxel—Immune system disorder—Estradiol—osteoporosis	9.58e-05	0.000454	CcSEcCtD
Docetaxel—Thrombocytopenia—Zoledronate—osteoporosis	9.57e-05	0.000454	CcSEcCtD
Docetaxel—Mediastinal disorder—Estradiol—osteoporosis	9.56e-05	0.000453	CcSEcCtD
Docetaxel—Dyspnoea—Pamidronate—osteoporosis	9.54e-05	0.000452	CcSEcCtD
Docetaxel—Tachycardia—Zoledronate—osteoporosis	9.54e-05	0.000452	CcSEcCtD
Docetaxel—Feeling abnormal—Ethinyl Estradiol—osteoporosis	9.52e-05	0.000451	CcSEcCtD
Docetaxel—Chills—Estradiol—osteoporosis	9.52e-05	0.000451	CcSEcCtD
Docetaxel—Somnolence—Pamidronate—osteoporosis	9.52e-05	0.000451	CcSEcCtD
Docetaxel—Skin disorder—Zoledronate—osteoporosis	9.5e-05	0.00045	CcSEcCtD
Docetaxel—Pruritus—Calcitriol—osteoporosis	9.46e-05	0.000448	CcSEcCtD
Docetaxel—Gastrointestinal pain—Ethinyl Estradiol—osteoporosis	9.44e-05	0.000447	CcSEcCtD
Docetaxel—Diarrhoea—Raloxifene—osteoporosis	9.44e-05	0.000447	CcSEcCtD
Docetaxel—Dyspepsia—Pamidronate—osteoporosis	9.42e-05	0.000446	CcSEcCtD
Docetaxel—Dizziness—Estropipate—osteoporosis	9.42e-05	0.000446	CcSEcCtD
Docetaxel—Anaphylactic shock—Conjugated Estrogens—osteoporosis	9.41e-05	0.000446	CcSEcCtD
Docetaxel—Oedema—Conjugated Estrogens—osteoporosis	9.41e-05	0.000446	CcSEcCtD
Docetaxel—Alopecia—Estradiol—osteoporosis	9.37e-05	0.000444	CcSEcCtD
Docetaxel—Infection—Conjugated Estrogens—osteoporosis	9.35e-05	0.000443	CcSEcCtD
Docetaxel—Diarrhoea—Ibandronate—osteoporosis	9.35e-05	0.000443	CcSEcCtD
Docetaxel—Anorexia—Zoledronate—osteoporosis	9.32e-05	0.000442	CcSEcCtD
Docetaxel—Decreased appetite—Pamidronate—osteoporosis	9.3e-05	0.000441	CcSEcCtD
Docetaxel—Mental disorder—Estradiol—osteoporosis	9.29e-05	0.00044	CcSEcCtD
Docetaxel—Dizziness—Alendronate—osteoporosis	9.28e-05	0.00044	CcSEcCtD
Docetaxel—Shock—Conjugated Estrogens—osteoporosis	9.26e-05	0.000439	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Pamidronate—osteoporosis	9.24e-05	0.000438	CcSEcCtD
Docetaxel—Nervous system disorder—Conjugated Estrogens—osteoporosis	9.23e-05	0.000437	CcSEcCtD
Docetaxel—Erythema—Estradiol—osteoporosis	9.23e-05	0.000437	CcSEcCtD
Docetaxel—Malnutrition—Estradiol—osteoporosis	9.23e-05	0.000437	CcSEcCtD
Docetaxel—Fatigue—Pamidronate—osteoporosis	9.23e-05	0.000437	CcSEcCtD
Docetaxel—Gastrointestinal pain—Risedronate—osteoporosis	9.21e-05	0.000436	CcSEcCtD
Docetaxel—Tachycardia—Conjugated Estrogens—osteoporosis	9.19e-05	0.000435	CcSEcCtD
Docetaxel—Constipation—Pamidronate—osteoporosis	9.15e-05	0.000434	CcSEcCtD
Docetaxel—Pain—Pamidronate—osteoporosis	9.15e-05	0.000434	CcSEcCtD
Docetaxel—Diarrhoea—Calcitriol—osteoporosis	9.15e-05	0.000434	CcSEcCtD
Docetaxel—Skin disorder—Conjugated Estrogens—osteoporosis	9.14e-05	0.000433	CcSEcCtD
Docetaxel—Hypotension—Zoledronate—osteoporosis	9.14e-05	0.000433	CcSEcCtD
Docetaxel—Abdominal pain—Ethinyl Estradiol—osteoporosis	9.13e-05	0.000433	CcSEcCtD
Docetaxel—Body temperature increased—Ethinyl Estradiol—osteoporosis	9.13e-05	0.000433	CcSEcCtD
Docetaxel—Dizziness—Raloxifene—osteoporosis	9.13e-05	0.000432	CcSEcCtD
Docetaxel—Vomiting—Estropipate—osteoporosis	9.06e-05	0.000429	CcSEcCtD
Docetaxel—Dysgeusia—Estradiol—osteoporosis	9.04e-05	0.000428	CcSEcCtD
Docetaxel—Dizziness—Ibandronate—osteoporosis	9.03e-05	0.000428	CcSEcCtD
Docetaxel—Rash—Estropipate—osteoporosis	8.98e-05	0.000426	CcSEcCtD
Docetaxel—Dermatitis—Estropipate—osteoporosis	8.98e-05	0.000425	CcSEcCtD
Docetaxel—Anorexia—Conjugated Estrogens—osteoporosis	8.97e-05	0.000425	CcSEcCtD
Docetaxel—Back pain—Estradiol—osteoporosis	8.93e-05	0.000423	CcSEcCtD
Docetaxel—Headache—Estropipate—osteoporosis	8.93e-05	0.000423	CcSEcCtD
Docetaxel—Vomiting—Alendronate—osteoporosis	8.92e-05	0.000423	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Zoledronate—osteoporosis	8.91e-05	0.000422	CcSEcCtD
Docetaxel—Body temperature increased—Risedronate—osteoporosis	8.9e-05	0.000422	CcSEcCtD
Docetaxel—Abdominal pain—Risedronate—osteoporosis	8.9e-05	0.000422	CcSEcCtD
Docetaxel—Muscle spasms—Estradiol—osteoporosis	8.88e-05	0.000421	CcSEcCtD
Docetaxel—Rash—Alendronate—osteoporosis	8.85e-05	0.000419	CcSEcCtD
Docetaxel—Insomnia—Zoledronate—osteoporosis	8.84e-05	0.000419	CcSEcCtD
Docetaxel—Dermatitis—Alendronate—osteoporosis	8.84e-05	0.000419	CcSEcCtD
Docetaxel—Feeling abnormal—Pamidronate—osteoporosis	8.82e-05	0.000418	CcSEcCtD
Docetaxel—Hypotension—Conjugated Estrogens—osteoporosis	8.8e-05	0.000417	CcSEcCtD
Docetaxel—Headache—Alendronate—osteoporosis	8.79e-05	0.000416	CcSEcCtD
Docetaxel—Paraesthesia—Zoledronate—osteoporosis	8.78e-05	0.000416	CcSEcCtD
Docetaxel—Vomiting—Raloxifene—osteoporosis	8.77e-05	0.000416	CcSEcCtD
Docetaxel—Gastrointestinal pain—Pamidronate—osteoporosis	8.75e-05	0.000415	CcSEcCtD
Docetaxel—Dyspnoea—Zoledronate—osteoporosis	8.72e-05	0.000413	CcSEcCtD
Docetaxel—Rash—Raloxifene—osteoporosis	8.7e-05	0.000412	CcSEcCtD
Docetaxel—Dermatitis—Raloxifene—osteoporosis	8.69e-05	0.000412	CcSEcCtD
Docetaxel—Somnolence—Zoledronate—osteoporosis	8.69e-05	0.000412	CcSEcCtD
Docetaxel—Vomiting—Ibandronate—osteoporosis	8.69e-05	0.000412	CcSEcCtD
Docetaxel—Headache—Raloxifene—osteoporosis	8.65e-05	0.00041	CcSEcCtD
Docetaxel—Rash—Ibandronate—osteoporosis	8.61e-05	0.000408	CcSEcCtD
Docetaxel—Dermatitis—Ibandronate—osteoporosis	8.61e-05	0.000408	CcSEcCtD
Docetaxel—Dyspepsia—Zoledronate—osteoporosis	8.61e-05	0.000408	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Conjugated Estrogens—osteoporosis	8.58e-05	0.000406	CcSEcCtD
Docetaxel—Headache—Ibandronate—osteoporosis	8.56e-05	0.000406	CcSEcCtD
Docetaxel—Insomnia—Conjugated Estrogens—osteoporosis	8.51e-05	0.000403	CcSEcCtD
Docetaxel—Hypersensitivity—Ethinyl Estradiol—osteoporosis	8.51e-05	0.000403	CcSEcCtD
Docetaxel—Vomiting—Calcitriol—osteoporosis	8.5e-05	0.000403	CcSEcCtD
Docetaxel—Decreased appetite—Zoledronate—osteoporosis	8.5e-05	0.000403	CcSEcCtD
Docetaxel—Nausea—Estropipate—osteoporosis	8.46e-05	0.000401	CcSEcCtD
Docetaxel—Abdominal pain—Pamidronate—osteoporosis	8.46e-05	0.000401	CcSEcCtD
Docetaxel—Body temperature increased—Pamidronate—osteoporosis	8.46e-05	0.000401	CcSEcCtD
Docetaxel—Paraesthesia—Conjugated Estrogens—osteoporosis	8.45e-05	0.0004	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Zoledronate—osteoporosis	8.44e-05	0.0004	CcSEcCtD
Docetaxel—Rash—Calcitriol—osteoporosis	8.43e-05	0.0004	CcSEcCtD
Docetaxel—Fatigue—Zoledronate—osteoporosis	8.43e-05	0.000399	CcSEcCtD
Docetaxel—Dermatitis—Calcitriol—osteoporosis	8.43e-05	0.000399	CcSEcCtD
Docetaxel—Dyspnoea—Conjugated Estrogens—osteoporosis	8.39e-05	0.000398	CcSEcCtD
Docetaxel—Headache—Calcitriol—osteoporosis	8.38e-05	0.000397	CcSEcCtD
Docetaxel—Somnolence—Conjugated Estrogens—osteoporosis	8.37e-05	0.000397	CcSEcCtD
Docetaxel—Pain—Zoledronate—osteoporosis	8.36e-05	0.000396	CcSEcCtD
Docetaxel—Constipation—Zoledronate—osteoporosis	8.36e-05	0.000396	CcSEcCtD
Docetaxel—Nausea—Alendronate—osteoporosis	8.34e-05	0.000395	CcSEcCtD
Docetaxel—Hypersensitivity—Risedronate—osteoporosis	8.3e-05	0.000393	CcSEcCtD
Docetaxel—Dyspepsia—Conjugated Estrogens—osteoporosis	8.29e-05	0.000393	CcSEcCtD
Docetaxel—Asthenia—Ethinyl Estradiol—osteoporosis	8.29e-05	0.000393	CcSEcCtD
Docetaxel—Syncope—Estradiol—osteoporosis	8.28e-05	0.000392	CcSEcCtD
Docetaxel—Nausea—Raloxifene—osteoporosis	8.2e-05	0.000388	CcSEcCtD
Docetaxel—Decreased appetite—Conjugated Estrogens—osteoporosis	8.18e-05	0.000388	CcSEcCtD
Docetaxel—Pruritus—Ethinyl Estradiol—osteoporosis	8.17e-05	0.000387	CcSEcCtD
Docetaxel—TUBB4A—uterus—osteoporosis	8.16e-05	0.0462	CbGeAlD
Docetaxel—Palpitations—Estradiol—osteoporosis	8.16e-05	0.000387	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Conjugated Estrogens—osteoporosis	8.13e-05	0.000385	CcSEcCtD
Docetaxel—Fatigue—Conjugated Estrogens—osteoporosis	8.12e-05	0.000385	CcSEcCtD
Docetaxel—Nausea—Ibandronate—osteoporosis	8.12e-05	0.000384	CcSEcCtD
Docetaxel—Loss of consciousness—Estradiol—osteoporosis	8.11e-05	0.000384	CcSEcCtD
Docetaxel—Asthenia—Risedronate—osteoporosis	8.08e-05	0.000383	CcSEcCtD
Docetaxel—Feeling abnormal—Zoledronate—osteoporosis	8.06e-05	0.000382	CcSEcCtD
Docetaxel—Cough—Estradiol—osteoporosis	8.06e-05	0.000382	CcSEcCtD
Docetaxel—Pain—Conjugated Estrogens—osteoporosis	8.05e-05	0.000381	CcSEcCtD
Docetaxel—Constipation—Conjugated Estrogens—osteoporosis	8.05e-05	0.000381	CcSEcCtD
Docetaxel—Gastrointestinal pain—Zoledronate—osteoporosis	7.99e-05	0.000379	CcSEcCtD
Docetaxel—Hypertension—Estradiol—osteoporosis	7.97e-05	0.000378	CcSEcCtD
Docetaxel—Pruritus—Risedronate—osteoporosis	7.97e-05	0.000377	CcSEcCtD
Docetaxel—Nausea—Calcitriol—osteoporosis	7.94e-05	0.000376	CcSEcCtD
Docetaxel—Diarrhoea—Ethinyl Estradiol—osteoporosis	7.9e-05	0.000374	CcSEcCtD
Docetaxel—Hypersensitivity—Pamidronate—osteoporosis	7.89e-05	0.000374	CcSEcCtD
Docetaxel—Myalgia—Estradiol—osteoporosis	7.86e-05	0.000372	CcSEcCtD
Docetaxel—Chest pain—Estradiol—osteoporosis	7.86e-05	0.000372	CcSEcCtD
Docetaxel—Arthralgia—Estradiol—osteoporosis	7.86e-05	0.000372	CcSEcCtD
Docetaxel—Unspecified disorder of skin and subcutaneous tissue—Estradiol—osteoporosis	7.81e-05	0.00037	CcSEcCtD
Docetaxel—Body temperature increased—Zoledronate—osteoporosis	7.73e-05	0.000366	CcSEcCtD
Docetaxel—Abdominal pain—Zoledronate—osteoporosis	7.73e-05	0.000366	CcSEcCtD
Docetaxel—Diarrhoea—Risedronate—osteoporosis	7.7e-05	0.000365	CcSEcCtD
Docetaxel—Gastrointestinal pain—Conjugated Estrogens—osteoporosis	7.7e-05	0.000365	CcSEcCtD
Docetaxel—Dry mouth—Estradiol—osteoporosis	7.69e-05	0.000364	CcSEcCtD
Docetaxel—Asthenia—Pamidronate—osteoporosis	7.68e-05	0.000364	CcSEcCtD
Docetaxel—Dizziness—Ethinyl Estradiol—osteoporosis	7.64e-05	0.000362	CcSEcCtD
Docetaxel—Confusional state—Estradiol—osteoporosis	7.6e-05	0.00036	CcSEcCtD
Docetaxel—Pruritus—Pamidronate—osteoporosis	7.57e-05	0.000359	CcSEcCtD
Docetaxel—Oedema—Estradiol—osteoporosis	7.53e-05	0.000357	CcSEcCtD
Docetaxel—Anaphylactic shock—Estradiol—osteoporosis	7.53e-05	0.000357	CcSEcCtD
Docetaxel—Infection—Estradiol—osteoporosis	7.49e-05	0.000355	CcSEcCtD
Docetaxel—TUBB—uterus—osteoporosis	7.47e-05	0.0423	CbGeAlD
Docetaxel—Dizziness—Risedronate—osteoporosis	7.45e-05	0.000353	CcSEcCtD
Docetaxel—Body temperature increased—Conjugated Estrogens—osteoporosis	7.44e-05	0.000353	CcSEcCtD
Docetaxel—Abdominal pain—Conjugated Estrogens—osteoporosis	7.44e-05	0.000353	CcSEcCtD
Docetaxel—TUBB2A—uterus—osteoporosis	7.43e-05	0.042	CbGeAlD
Docetaxel—Shock—Estradiol—osteoporosis	7.41e-05	0.000351	CcSEcCtD
Docetaxel—Nervous system disorder—Estradiol—osteoporosis	7.39e-05	0.00035	CcSEcCtD
Docetaxel—Tachycardia—Estradiol—osteoporosis	7.35e-05	0.000348	CcSEcCtD
Docetaxel—Vomiting—Ethinyl Estradiol—osteoporosis	7.34e-05	0.000348	CcSEcCtD
Docetaxel—TUBB6—uterus—osteoporosis	7.32e-05	0.0415	CbGeAlD
Docetaxel—Diarrhoea—Pamidronate—osteoporosis	7.32e-05	0.000347	CcSEcCtD
Docetaxel—Skin disorder—Estradiol—osteoporosis	7.32e-05	0.000347	CcSEcCtD
Docetaxel—Rash—Ethinyl Estradiol—osteoporosis	7.28e-05	0.000345	CcSEcCtD
Docetaxel—Dermatitis—Ethinyl Estradiol—osteoporosis	7.27e-05	0.000345	CcSEcCtD
Docetaxel—Headache—Ethinyl Estradiol—osteoporosis	7.23e-05	0.000343	CcSEcCtD
Docetaxel—Hypersensitivity—Zoledronate—osteoporosis	7.2e-05	0.000341	CcSEcCtD
Docetaxel—Vomiting—Risedronate—osteoporosis	7.16e-05	0.000339	CcSEcCtD
Docetaxel—Rash—Risedronate—osteoporosis	7.1e-05	0.000336	CcSEcCtD
Docetaxel—Dermatitis—Risedronate—osteoporosis	7.09e-05	0.000336	CcSEcCtD
Docetaxel—Dizziness—Pamidronate—osteoporosis	7.08e-05	0.000335	CcSEcCtD
Docetaxel—Headache—Risedronate—osteoporosis	7.05e-05	0.000334	CcSEcCtD
Docetaxel—Asthenia—Zoledronate—osteoporosis	7.01e-05	0.000332	CcSEcCtD
Docetaxel—Hypersensitivity—Conjugated Estrogens—osteoporosis	6.94e-05	0.000329	CcSEcCtD
Docetaxel—Pruritus—Zoledronate—osteoporosis	6.92e-05	0.000328	CcSEcCtD
Docetaxel—Musculoskeletal discomfort—Estradiol—osteoporosis	6.86e-05	0.000325	CcSEcCtD
Docetaxel—Nausea—Ethinyl Estradiol—osteoporosis	6.86e-05	0.000325	CcSEcCtD
Docetaxel—Insomnia—Estradiol—osteoporosis	6.81e-05	0.000323	CcSEcCtD
Docetaxel—Vomiting—Pamidronate—osteoporosis	6.81e-05	0.000322	CcSEcCtD
Docetaxel—Paraesthesia—Estradiol—osteoporosis	6.77e-05	0.000321	CcSEcCtD
Docetaxel—Asthenia—Conjugated Estrogens—osteoporosis	6.75e-05	0.00032	CcSEcCtD
Docetaxel—Rash—Pamidronate—osteoporosis	6.75e-05	0.00032	CcSEcCtD
Docetaxel—Dermatitis—Pamidronate—osteoporosis	6.74e-05	0.000319	CcSEcCtD
Docetaxel—Dyspnoea—Estradiol—osteoporosis	6.72e-05	0.000318	CcSEcCtD
Docetaxel—Headache—Pamidronate—osteoporosis	6.71e-05	0.000318	CcSEcCtD
Docetaxel—Somnolence—Estradiol—osteoporosis	6.7e-05	0.000317	CcSEcCtD
Docetaxel—Diarrhoea—Zoledronate—osteoporosis	6.69e-05	0.000317	CcSEcCtD
Docetaxel—Nausea—Risedronate—osteoporosis	6.69e-05	0.000317	CcSEcCtD
Docetaxel—Pruritus—Conjugated Estrogens—osteoporosis	6.66e-05	0.000316	CcSEcCtD
Docetaxel—Dyspepsia—Estradiol—osteoporosis	6.63e-05	0.000314	CcSEcCtD
Docetaxel—Decreased appetite—Estradiol—osteoporosis	6.55e-05	0.00031	CcSEcCtD
Docetaxel—Gastrointestinal disorder—Estradiol—osteoporosis	6.5e-05	0.000308	CcSEcCtD
Docetaxel—Fatigue—Estradiol—osteoporosis	6.5e-05	0.000308	CcSEcCtD
Docetaxel—Dizziness—Zoledronate—osteoporosis	6.47e-05	0.000306	CcSEcCtD
Docetaxel—Constipation—Estradiol—osteoporosis	6.44e-05	0.000305	CcSEcCtD
Docetaxel—Pain—Estradiol—osteoporosis	6.44e-05	0.000305	CcSEcCtD
Docetaxel—Diarrhoea—Conjugated Estrogens—osteoporosis	6.44e-05	0.000305	CcSEcCtD
Docetaxel—ABCC10—uterus—osteoporosis	6.41e-05	0.0363	CbGeAlD
Docetaxel—TUBB4B—uterus—osteoporosis	6.37e-05	0.036	CbGeAlD
Docetaxel—Nausea—Pamidronate—osteoporosis	6.36e-05	0.000301	CcSEcCtD
Docetaxel—TUBB—bone marrow—osteoporosis	6.34e-05	0.0359	CbGeAlD
Docetaxel—TUBB2A—bone marrow—osteoporosis	6.3e-05	0.0357	CbGeAlD
Docetaxel—Dizziness—Conjugated Estrogens—osteoporosis	6.23e-05	0.000295	CcSEcCtD
Docetaxel—Vomiting—Zoledronate—osteoporosis	6.22e-05	0.000295	CcSEcCtD
Docetaxel—TUBB6—bone marrow—osteoporosis	6.22e-05	0.0352	CbGeAlD
Docetaxel—Feeling abnormal—Estradiol—osteoporosis	6.21e-05	0.000294	CcSEcCtD
Docetaxel—Rash—Zoledronate—osteoporosis	6.16e-05	0.000292	CcSEcCtD
Docetaxel—Gastrointestinal pain—Estradiol—osteoporosis	6.16e-05	0.000292	CcSEcCtD
Docetaxel—Dermatitis—Zoledronate—osteoporosis	6.16e-05	0.000292	CcSEcCtD
Docetaxel—Headache—Zoledronate—osteoporosis	6.12e-05	0.00029	CcSEcCtD
Docetaxel—Vomiting—Conjugated Estrogens—osteoporosis	5.99e-05	0.000284	CcSEcCtD
Docetaxel—Abdominal pain—Estradiol—osteoporosis	5.96e-05	0.000282	CcSEcCtD
Docetaxel—Body temperature increased—Estradiol—osteoporosis	5.96e-05	0.000282	CcSEcCtD
Docetaxel—Rash—Conjugated Estrogens—osteoporosis	5.94e-05	0.000281	CcSEcCtD
Docetaxel—Dermatitis—Conjugated Estrogens—osteoporosis	5.93e-05	0.000281	CcSEcCtD
Docetaxel—Headache—Conjugated Estrogens—osteoporosis	5.9e-05	0.000279	CcSEcCtD
Docetaxel—Nausea—Zoledronate—osteoporosis	5.81e-05	0.000275	CcSEcCtD
Docetaxel—Nausea—Conjugated Estrogens—osteoporosis	5.59e-05	0.000265	CcSEcCtD
Docetaxel—Hypersensitivity—Estradiol—osteoporosis	5.55e-05	0.000263	CcSEcCtD
Docetaxel—ABCC10—bone marrow—osteoporosis	5.44e-05	0.0308	CbGeAlD
Docetaxel—Asthenia—Estradiol—osteoporosis	5.41e-05	0.000256	CcSEcCtD
Docetaxel—TUBB4B—bone marrow—osteoporosis	5.4e-05	0.0306	CbGeAlD
Docetaxel—Pruritus—Estradiol—osteoporosis	5.33e-05	0.000253	CcSEcCtD
Docetaxel—Diarrhoea—Estradiol—osteoporosis	5.16e-05	0.000244	CcSEcCtD
Docetaxel—CYP1B1—uterus—osteoporosis	5.04e-05	0.0285	CbGeAlD
Docetaxel—Dizziness—Estradiol—osteoporosis	4.98e-05	0.000236	CcSEcCtD
Docetaxel—Vomiting—Estradiol—osteoporosis	4.79e-05	0.000227	CcSEcCtD
Docetaxel—Rash—Estradiol—osteoporosis	4.75e-05	0.000225	CcSEcCtD
Docetaxel—Dermatitis—Estradiol—osteoporosis	4.75e-05	0.000225	CcSEcCtD
Docetaxel—Headache—Estradiol—osteoporosis	4.72e-05	0.000224	CcSEcCtD
Docetaxel—ABCC1—uterus—osteoporosis	4.54e-05	0.0257	CbGeAlD
Docetaxel—Nausea—Estradiol—osteoporosis	4.48e-05	0.000212	CcSEcCtD
Docetaxel—ABCG2—uterus—osteoporosis	3.76e-05	0.0213	CbGeAlD
Docetaxel—ABCG2—bone marrow—osteoporosis	3.19e-05	0.018	CbGeAlD
Docetaxel—ABCB1—uterus—osteoporosis	1.85e-05	0.0105	CbGeAlD
Docetaxel—ABCB1—bone marrow—osteoporosis	1.57e-05	0.0089	CbGeAlD
Docetaxel—EGFR—Signaling by SCF-KIT—IL6—osteoporosis	1.23e-05	7.49e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—DKK1—osteoporosis	1.23e-05	7.48e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—ADCY5—osteoporosis	1.23e-05	7.48e-05	CbGpPWpGaD
Docetaxel—ABCB1—Allograft Rejection—TNF—osteoporosis	1.23e-05	7.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—FGA—osteoporosis	1.23e-05	7.44e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP27A1—osteoporosis	1.23e-05	7.44e-05	CbGpPWpGaD
Docetaxel—TUBB—Cell Cycle—MYC—osteoporosis	1.22e-05	7.42e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—TPI1—osteoporosis	1.22e-05	7.39e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP27A1—osteoporosis	1.21e-05	7.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—LEP—osteoporosis	1.21e-05	7.36e-05	CbGpPWpGaD
Docetaxel—EGFR—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	1.2e-05	7.28e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ACP5—osteoporosis	1.19e-05	7.23e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—WNT1—osteoporosis	1.19e-05	7.21e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—P4HB—osteoporosis	1.18e-05	7.19e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ACP5—osteoporosis	1.18e-05	7.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Downstream signaling of activated FGFR—IL6—osteoporosis	1.18e-05	7.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB4—IL6—osteoporosis	1.16e-05	7.05e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GAPDH—osteoporosis	1.16e-05	7.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—FGA—osteoporosis	1.16e-05	7.01e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PKM—osteoporosis	1.15e-05	7e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—FDPS—osteoporosis	1.15e-05	7e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—P4HB—osteoporosis	1.15e-05	6.95e-05	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle, Mitotic—MYC—osteoporosis	1.13e-05	6.87e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—RAP1A—osteoporosis	1.13e-05	6.87e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CA2—osteoporosis	1.13e-05	6.84e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—OXCT1—osteoporosis	1.13e-05	6.84e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GAPDH—osteoporosis	1.12e-05	6.82e-05	CbGpPWpGaD
Docetaxel—ABCG2—Transmembrane transport of small molecules—ADCY5—osteoporosis	1.12e-05	6.81e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—CALCA—osteoporosis	1.12e-05	6.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Downstream signal transduction—IL6—osteoporosis	1.11e-05	6.74e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—TPI1—osteoporosis	1.11e-05	6.73e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR—IL6—osteoporosis	1.1e-05	6.7e-05	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—MYC—osteoporosis	1.1e-05	6.69e-05	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—TGFB1—osteoporosis	1.1e-05	6.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by ERBB2—IL6—osteoporosis	1.1e-05	6.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PSMA2—osteoporosis	1.1e-05	6.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—PSMA5—osteoporosis	1.1e-05	6.67e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—TPI1—osteoporosis	1.1e-05	6.67e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MGLL—osteoporosis	1.1e-05	6.66e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—RAP1A—osteoporosis	1.09e-05	6.64e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IRS2—osteoporosis	1.09e-05	6.64e-05	CbGpPWpGaD
Docetaxel—EGFR—DAP12 signaling—IL6—osteoporosis	1.09e-05	6.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PGLS—osteoporosis	1.09e-05	6.64e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPD2—osteoporosis	1.09e-05	6.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ENO1—osteoporosis	1.09e-05	6.63e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TLN1—osteoporosis	1.08e-05	6.57e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—osteoporosis	1.08e-05	6.57e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IRS2—osteoporosis	1.08e-05	6.54e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PSMA2—osteoporosis	1.08e-05	6.53e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—PSMA5—osteoporosis	1.08e-05	6.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—IRS2—osteoporosis	1.05e-05	6.38e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—P4HB—osteoporosis	1.04e-05	6.32e-05	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle, Mitotic—MYC—osteoporosis	1.04e-05	6.29e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—CYP19A1—osteoporosis	1.03e-05	6.28e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—P4HB—osteoporosis	1.03e-05	6.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ENO1—osteoporosis	1.03e-05	6.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by FGFR in disease—IL6—osteoporosis	1.03e-05	6.25e-05	CbGpPWpGaD
Docetaxel—EGFR—Fc epsilon receptor (FCERI) signaling—IL6—osteoporosis	1.03e-05	6.25e-05	CbGpPWpGaD
Docetaxel—EGFR—DAP12 interactions—IL6—osteoporosis	1.03e-05	6.25e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GAPDH—osteoporosis	1.02e-05	6.21e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR—IL6—osteoporosis	1.02e-05	6.19e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6R—osteoporosis	1.02e-05	6.17e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PSMA2—osteoporosis	1.01e-05	6.16e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—PSMA5—osteoporosis	1.01e-05	6.16e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GAPDH—osteoporosis	1.01e-05	6.15e-05	CbGpPWpGaD
Docetaxel—TUBB4A—Cell Cycle—MYC—osteoporosis	1.01e-05	6.14e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by EGFR in Cancer—IL6—osteoporosis	1.01e-05	6.13e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by PDGF—IL6—osteoporosis	1.01e-05	6.11e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—CALCA—osteoporosis	1e-05	6.09e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PNP—osteoporosis	1e-05	6.07e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ATIC—osteoporosis	1e-05	6.07e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—RAP1A—osteoporosis	9.96e-06	6.05e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—RAP1A—osteoporosis	9.87e-06	5.99e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.87e-06	5.99e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IRS1—osteoporosis	9.55e-06	5.8e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism of lipids and lipoproteins—POMC—osteoporosis	9.55e-06	5.79e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—CALCA—osteoporosis	9.46e-06	5.74e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IRS1—osteoporosis	9.41e-06	5.71e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—IDH2—osteoporosis	9.34e-06	5.67e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—P4HB—osteoporosis	9.33e-06	5.66e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—KL—osteoporosis	9.3e-06	5.64e-05	CbGpPWpGaD
Docetaxel—TUBB4B—Cell Cycle—MYC—osteoporosis	9.26e-06	5.62e-05	CbGpPWpGaD
Docetaxel—EGFR—Adaptive Immune System—IRS1—osteoporosis	9.17e-06	5.57e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ENO1—osteoporosis	9.15e-06	5.55e-05	CbGpPWpGaD
Docetaxel—EGFR—NGF signalling via TRKA from the plasma membrane—IL6—osteoporosis	9.11e-06	5.53e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—KL—osteoporosis	9.11e-06	5.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTH—osteoporosis	9.08e-06	5.51e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PSMA5—osteoporosis	9.02e-06	5.47e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—PSMA2—osteoporosis	9.02e-06	5.47e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6R—osteoporosis	8.98e-06	5.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—RAP1A—osteoporosis	8.92e-06	5.41e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ENO1—osteoporosis	8.85e-06	5.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CNR2—osteoporosis	8.85e-06	5.37e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6R—osteoporosis	8.84e-06	5.37e-05	CbGpPWpGaD
Docetaxel—EGFR—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—osteoporosis	8.81e-06	5.35e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP27A1—osteoporosis	8.78e-06	5.33e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PSMA2—osteoporosis	8.72e-06	5.29e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—PSMA5—osteoporosis	8.72e-06	5.29e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—NFATC1—osteoporosis	8.7e-06	5.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—DKK1—osteoporosis	8.63e-06	5.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—KL—osteoporosis	8.59e-06	5.21e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ACP5—osteoporosis	8.54e-06	5.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—OXCT1—osteoporosis	8.5e-06	5.16e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CA2—osteoporosis	8.5e-06	5.16e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—ADCY5—osteoporosis	8.45e-06	5.13e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—GPX1—osteoporosis	8.42e-06	5.11e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—WNT1—osteoporosis	8.32e-06	5.05e-05	CbGpPWpGaD
Docetaxel—GHRHR—Signaling Pathways—IL6—osteoporosis	8.29e-06	5.03e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MGLL—osteoporosis	8.29e-06	5.03e-05	CbGpPWpGaD
Docetaxel—NR1I2—Gene Expression—MYC—osteoporosis	8.28e-06	5.03e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGA—osteoporosis	8.09e-06	4.91e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ENO1—osteoporosis	8.05e-06	4.89e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ENO1—osteoporosis	7.98e-06	4.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—ADCY5—osteoporosis	7.97e-06	4.84e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—TPI1—osteoporosis	7.94e-06	4.82e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PSMA2—osteoporosis	7.93e-06	4.82e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—PSMA5—osteoporosis	7.93e-06	4.82e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PSMA5—osteoporosis	7.86e-06	4.77e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—PSMA2—osteoporosis	7.86e-06	4.77e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—MTHFR—osteoporosis	7.77e-06	4.72e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Biological oxidations—POMC—osteoporosis	7.53e-06	4.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PTHLH—osteoporosis	7.52e-06	4.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—BMP2—osteoporosis	7.52e-06	4.57e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—P4HB—osteoporosis	7.46e-06	4.53e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—FGB—osteoporosis	7.36e-06	4.47e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GAPDH—osteoporosis	7.33e-06	4.45e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—CYP19A1—osteoporosis	7.31e-06	4.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—AGER—osteoporosis	7.31e-06	4.44e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—ADCY5—osteoporosis	7.29e-06	4.42e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—ADCY5—osteoporosis	7.14e-06	4.33e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—RAP1A—osteoporosis	7.14e-06	4.33e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PKM—osteoporosis	7.11e-06	4.31e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—FDPS—osteoporosis	7.11e-06	4.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PSMA5—osteoporosis	7.11e-06	4.31e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—PSMA2—osteoporosis	7.11e-06	4.31e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—CYP19A1—osteoporosis	7.07e-06	4.29e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—IDH2—osteoporosis	7.05e-06	4.28e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by NGF—IL6—osteoporosis	7.01e-06	4.25e-05	CbGpPWpGaD
Docetaxel—BCL2—Innate Immune System—IL6—osteoporosis	6.76e-06	4.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PGLS—osteoporosis	6.74e-06	4.09e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPD2—osteoporosis	6.74e-06	4.09e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—ADCY5—osteoporosis	6.73e-06	4.08e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL1B—osteoporosis	6.73e-06	4.08e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP27A1—osteoporosis	6.62e-06	4.02e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—CALCA—osteoporosis	6.62e-06	4.02e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MTHFR—osteoporosis	6.56e-06	3.98e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—osteoporosis	6.5e-06	3.95e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—osteoporosis	6.49e-06	3.94e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ACP5—osteoporosis	6.44e-06	3.91e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—CYP19A1—osteoporosis	6.44e-06	3.91e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—CYP19A1—osteoporosis	6.38e-06	3.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRS2—osteoporosis	6.37e-06	3.87e-05	CbGpPWpGaD
Docetaxel—EGFR—Axon guidance—IL6—osteoporosis	6.34e-06	3.85e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IRS2—osteoporosis	6.24e-06	3.79e-05	CbGpPWpGaD
Docetaxel—SLCO1B3—Metabolism—POMC—osteoporosis	6.22e-06	3.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MTHFR—osteoporosis	6.19e-06	3.75e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PNP—osteoporosis	6.16e-06	3.74e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ATIC—osteoporosis	6.16e-06	3.74e-05	CbGpPWpGaD
Docetaxel—ABCB1—Transmembrane transport of small molecules—ADCY5—osteoporosis	6.07e-06	3.68e-05	CbGpPWpGaD
Docetaxel—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—osteoporosis	6.06e-06	3.68e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—KL—osteoporosis	6.01e-06	3.65e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TGFB1—osteoporosis	6.01e-06	3.65e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—TPI1—osteoporosis	5.99e-06	3.64e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—ADCY5—osteoporosis	5.98e-06	3.63e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—GPX1—osteoporosis	5.96e-06	3.61e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IRS2—osteoporosis	5.89e-06	3.57e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—POMC—osteoporosis	5.87e-06	3.56e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—ADCY5—osteoporosis	5.78e-06	3.51e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ENO1—osteoporosis	5.77e-06	3.5e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—GPX1—osteoporosis	5.76e-06	3.5e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6R—osteoporosis	5.72e-06	3.47e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PSMA2—osteoporosis	5.68e-06	3.45e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—PSMA5—osteoporosis	5.68e-06	3.45e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—P4HB—osteoporosis	5.63e-06	3.42e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—TNF—osteoporosis	5.61e-06	3.4e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IRS1—osteoporosis	5.56e-06	3.38e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GAPDH—osteoporosis	5.53e-06	3.36e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—MTHFR—osteoporosis	5.5e-06	3.34e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IRS1—osteoporosis	5.45e-06	3.31e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—RAP1A—osteoporosis	5.38e-06	3.27e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—MTHFR—osteoporosis	5.32e-06	3.23e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—ADCY5—osteoporosis	5.26e-06	3.19e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—GPX1—osteoporosis	5.24e-06	3.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CA2—osteoporosis	5.24e-06	3.18e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—OXCT1—osteoporosis	5.24e-06	3.18e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6R—osteoporosis	5.23e-06	3.17e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—ADCY5—osteoporosis	5.21e-06	3.16e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—GPX1—osteoporosis	5.19e-06	3.15e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IRS1—osteoporosis	5.14e-06	3.12e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6R—osteoporosis	5.12e-06	3.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MGLL—osteoporosis	5.11e-06	3.1e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—MTHFR—osteoporosis	4.84e-06	2.94e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6R—osteoporosis	4.83e-06	2.93e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—MTHFR—osteoporosis	4.79e-06	2.91e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ADCY5—osteoporosis	4.71e-06	2.86e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—CYP19A1—osteoporosis	4.61e-06	2.8e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—SPP1—osteoporosis	4.56e-06	2.77e-05	CbGpPWpGaD
Docetaxel—EGFR—Developmental Biology—IL6—osteoporosis	4.53e-06	2.75e-05	CbGpPWpGaD
Docetaxel—ABCC1—Metabolism—POMC—osteoporosis	4.4e-06	2.67e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ENO1—osteoporosis	4.35e-06	2.64e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—IDH2—osteoporosis	4.34e-06	2.63e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSMA2—osteoporosis	4.29e-06	2.6e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—PSMA5—osteoporosis	4.29e-06	2.6e-05	CbGpPWpGaD
Docetaxel—CYP1B1—Metabolism—POMC—osteoporosis	4.25e-06	2.58e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS2—osteoporosis	4.12e-06	2.5e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP27A1—osteoporosis	4.08e-06	2.48e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—LEP—osteoporosis	4.03e-06	2.45e-05	CbGpPWpGaD
Docetaxel—EGFR—Innate Immune System—IL6—osteoporosis	4e-06	2.43e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL1B—osteoporosis	3.98e-06	2.41e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ACP5—osteoporosis	3.97e-06	2.41e-05	CbGpPWpGaD
Docetaxel—BCL2—Immune System—IL6—osteoporosis	3.94e-06	2.39e-05	CbGpPWpGaD
Docetaxel—ABCG2—Metabolism—POMC—osteoporosis	3.87e-06	2.35e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—ESR1—osteoporosis	3.85e-06	2.34e-05	CbGpPWpGaD
Docetaxel—CYP3A7—Metabolism—POMC—osteoporosis	3.83e-06	2.33e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—ADCY5—osteoporosis	3.77e-06	2.29e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—GPX1—osteoporosis	3.76e-06	2.28e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—TPI1—osteoporosis	3.69e-06	2.24e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IRS1—osteoporosis	3.6e-06	2.18e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—CYP19A1—osteoporosis	3.48e-06	2.11e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—P4HB—osteoporosis	3.47e-06	2.11e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—MTHFR—osteoporosis	3.47e-06	2.1e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—POMC—osteoporosis	3.46e-06	2.1e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GAPDH—osteoporosis	3.41e-06	2.07e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6R—osteoporosis	3.38e-06	2.05e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IGF1—osteoporosis	3.33e-06	2.02e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—RAP1A—osteoporosis	3.32e-06	2.01e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—MYC—osteoporosis	3.03e-06	1.84e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—TGFB1—osteoporosis	3.03e-06	1.84e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—MYC—osteoporosis	2.86e-06	1.74e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—TGFB1—osteoporosis	2.85e-06	1.73e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—ADCY5—osteoporosis	2.84e-06	1.73e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—GPX1—osteoporosis	2.83e-06	1.72e-05	CbGpPWpGaD
Docetaxel—CYP3A5—Metabolism—POMC—osteoporosis	2.77e-06	1.68e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ENO1—osteoporosis	2.68e-06	1.63e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSMA2—osteoporosis	2.64e-06	1.6e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—PSMA5—osteoporosis	2.64e-06	1.6e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—MTHFR—osteoporosis	2.62e-06	1.59e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling by GPCR—IL6—osteoporosis	2.55e-06	1.55e-05	CbGpPWpGaD
Docetaxel—EGFR—Immune System—IL6—osteoporosis	2.33e-06	1.41e-05	CbGpPWpGaD
Docetaxel—ABCC1—Disease—IL6—osteoporosis	2.28e-06	1.38e-05	CbGpPWpGaD
Docetaxel—EGFR—Disease—IL6—osteoporosis	2.15e-06	1.3e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—CYP19A1—osteoporosis	2.14e-06	1.3e-05	CbGpPWpGaD
Docetaxel—ABCB1—Metabolism—POMC—osteoporosis	2.09e-06	1.27e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—MYC—osteoporosis	2e-06	1.22e-05	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—TGFB1—osteoporosis	2e-06	1.21e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—ADCY5—osteoporosis	1.75e-06	1.06e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—GPX1—osteoporosis	1.75e-06	1.06e-05	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—MTHFR—osteoporosis	1.61e-06	9.78e-06	CbGpPWpGaD
Docetaxel—EGFR—Signaling Pathways—IL6—osteoporosis	1.51e-06	9.14e-06	CbGpPWpGaD
Docetaxel—CYP3A4—Metabolism—POMC—osteoporosis	1.29e-06	7.82e-06	CbGpPWpGaD
